|
Market Closed -
OTC Markets
15:50:39 2026-06-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.0785 USD | +3.29% |
|
-0.38% | -16.45% |
| 08-13 | MariMed Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-12 | MariMed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 29.46M 25.69M 24.26M 22.03M 41.27M 2.83B 41.44M 291M 112M 1.44B 111M 108M 4.62B | P/E 2026 * |
-1.83x | P/E 2027 * | -2.44x |
|---|---|---|---|---|---|
| Enterprise Value | -44.06M -38.42M -36.28M -32.94M -61.72M -4.23B -61.98M -435M -168M -2.15B -166M -162M -6.92B | EV / Sales 2026 * |
-0.27x | EV / Sales 2027 * | -0.26x |
| Free-Float |
85.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: MariMed Inc.
| 1 day | +3.29% | ||
| 1 week | -0.38% | ||
| Current month | -3.74% | ||
| 1 month | +13.77% | ||
| 3 months | +12.14% | ||
| 6 months | +4.53% | ||
| Current year | -16.45% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.07 | | 0.09 |
| Current year | 0.06 | | 0.1 |
| 1 year | 0.06 | | 0.18 |
| 3 years | 0.06 | | 0.49 |
| 5 years | 0.06 | | 1 |
| 10 years | 0.06 | | 5.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Levine
CEO | Chief Executive Officer | 61 | 2022-12-13 |
Mario Pinho
DFI | Director of Finance/CFO | 58 | 2024-08-08 |
Jay O’Malley
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Gildea
CHM | Chairman | 74 | 2023-02-27 |
Jon Levine
BRD | Director/Board Member | 61 | 2015-12-31 |
David Allen
BRD | Director/Board Member | 71 | 2019-06-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Exercice | Chief Operating Officer | 152,523 | 0.0378% | ||
| 9/1/26 | Option | Chief Operating Officer | -65,000 | 0.0161% | ||
| 9/1/26 | Tax | Chief Operating Officer | -22,523 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | -0.38% | -43.73% | -84.25% | 29.46M | |
| -4.98% | -2.12% | +50.00% | +52.69% | 2.13B | |
| -0.97% | +2.93% | -5.38% | -33.33% | 1.59B | |
| -0.25% | +0.50% | +10.39% | +75.16% | 751M | |
| -3.23% | +2.87% | -34.73% | +45.34% | 225M | |
| +1.10% | +5.75% | -23.33% | -67.49% | 203M | |
| +6.40% | +7.29% | -7.48% | -20.20% | 127M | |
| -2.87% | -3.21% | +47.68% | -44.47% | 77.51M | |
| Average | -0.19% | +1.65% | -0.82% | -9.57% | 642.16M | |
| Weighted average by Cap. | -2.37% | +0.33% | +18.44% | +20.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 162M 142M 134M 121M 227M 15.58B 228M 1.6B 618M 7.92B 610M 597M 25.49B | 168M 146M 138M 125M 235M 16.1B 236M 1.65B 639M 8.19B 630M 616M 26.34B |
| Net income | -14.96M -13.04M -12.32M -11.18M -20.96M -1.44B -21.04M -148M -56.93M -730M -56.19M -54.95M -2.35B | -10.79M -9.41M -8.88M -8.07M -15.11M -1.04B -15.17M -106M -41.06M -526M -40.52M -39.62M -1.69B |
| Net Debt | -73.52M -64.11M -60.53M -54.97M -103M -7.05B -103M -725M -280M -3.59B -276M -270M -11.54B | -73.7M -64.26M -60.68M -55.1M -103M -7.07B -104M -727M -280M -3.6B -277M -271M -11.57B |
Employees
866
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$0.0731 | -1.22% | 610,627 |
| 26-09-17 | US$0.0740 | +3.50% | 816,560 |
| 26-09-16 | US$0.0715 | -3.04% | 228,635 |
| 26-09-15 | US$0.0737 | -4.48% | 486,047 |
| 26-09-14 | US$0.0772 | -2.03% | 1,137,865 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0731
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRMD Stock
Select your edition
All financial news and data tailored to specific country editions
